Look at Bladder Cancer Advocacy Network - They wait for MCNA
Some reactions of NMIBC patients here:
Possible advancement in treatment of NMIBC
Telesta Therapeutics applied for a license from the FDA for their therapy, MCNA. MCNA is Telesta's novel biologic immunotherapeutic for the treatment of high-risk non-muscle invasive bladder cancer patients who have failed first-line BCG therapy.
https://www.inspire.com/groups/bladder-cancer-advocacy-network/discussion/possible-advancement-in-treatment-of-nmibc/
Hope the FDA approval/license comes quickly! This could benefit so many in the BC community.